Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentCombining radiotherapy and cancer immunotherapy: a paradigm shiftThe roles of Galectin-3 in autoimmunity and tumor progressionTwo-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerTumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumorsAdoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in miceStrategies to overcome obstacles to successful immunotherapy of melanomaUse of tumour-responsive T cells as cancer treatment.Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice.Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.(R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatmentMicroarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapyA pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma.Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.Defining the critical hurdles in cancer immunotherapy.Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.Combining radiotherapy and immunotherapy: a revived partnership.High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.Checkpoint blockade in cancer immunotherapyHurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.Vaccination: role in metastatic melanoma.NY-ESO-1 immunotherapy for multiple myeloma.Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityImmune correlates of melanoma survival in adoptive cell therapy.Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathwayTumor-associated antigens and biomarkers in cancer and immune therapy.Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
P2860
Q21131200-DC9ACC06-EFD8-4B31-B39B-E14986F72A9AQ26799117-B0B51E53-F8AF-497B-834D-C4BC4943C733Q27021428-2863482C-1579-4D07-ADC9-2184EF5E6A06Q28261890-CA84F627-6CF2-4B22-A1F9-9C4C4990C700Q30481516-84C9CB63-7979-4F7F-8D32-979309E1B331Q30525394-B15F8645-A929-4B34-B38D-256B8666EF85Q30846001-8B960D1B-858C-4378-8875-25334EB7FCA4Q33530527-5E57EE55-E6A9-4C37-BD5E-F8B4E0273414Q33613602-AA06EA54-945E-4B91-95F3-AE52717CCED3Q33765767-F898D7B2-4648-4E6B-9247-C9D00D898A87Q33776452-F156CF3B-1A11-4CCF-A573-A60D06846500Q34042968-43564171-6788-4519-AEA7-EB79832A885CQ34285656-EC86D4C7-A85E-450E-BDCE-B794ACE890EEQ34448082-016B5147-B077-43B0-B191-09A91E0A49A8Q34627677-8E21A077-E094-42C7-9515-CD51BF24B30CQ34691545-CBFCC804-6AD9-4FE3-BA72-AA3524669808Q34736597-8B035664-7C41-44FA-A7CB-46CE8D997D18Q35012393-B7A6815B-964E-4765-8C13-A8D3A9AD5BEEQ35201915-90B6F13A-99A2-46CC-B1F3-346A2D899715Q35751259-8188760C-1336-475D-A80A-C985151B6E50Q35889604-28B1E445-BE9C-42BC-9313-4271D1DFEB14Q35916968-1EF793A4-0192-457B-9B74-97573AFCD52CQ35939427-E415EFDB-43D6-43E4-A521-075C6FAB3FE7Q36071705-AB586097-E4E8-4430-A49E-0E945BCF4DEBQ36185636-F0EDEC9F-A838-4638-8D26-F0DEEA3691CFQ36228011-894B8DF9-296F-46FA-9E18-C338EADCB762Q36229738-DE019A06-FBE3-4A02-8529-BBA8306B521EQ36274581-0A56BB80-E19E-481E-B2A4-250D44CCF55DQ36402611-1455305B-1482-4476-9F37-1DD3C520967BQ36490768-0D2A1746-DAFE-4A4B-B818-9B6ED941E1F7Q36568984-A7AC6094-32E1-49E7-A1F0-578E8A3C783BQ36573868-E030357C-714F-4A16-9C29-60A174A040E9Q36637651-D4905DBC-CECA-4E3A-9471-C51A268AB637Q36664213-A90715E8-04F6-437B-B4C1-B8D3C49D9F70Q36693023-1F2E0F8B-8441-4E41-9F67-6F154108CD16Q36694896-4B74F03E-A01E-4833-9F18-F8D0A094B5B6Q36742295-F57A8087-A38C-4C3E-9152-07433C0A10C5Q36786880-677A2439-1833-449E-AB5A-2441FB4AEF45Q36844959-B6A1CB40-6955-410D-9358-CF00683D651AQ36859171-FEFF26EB-54DC-404E-A9EC-B58D2679C296
P2860
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Contrasting frequencies of ant ...... ted with a MAGE tumor antigen.
@en
type
label
Contrasting frequencies of ant ...... ted with a MAGE tumor antigen.
@en
prefLabel
Contrasting frequencies of ant ...... ted with a MAGE tumor antigen.
@en
P2093
P2860
P356
P1476
Contrasting frequencies of ant ...... ted with a MAGE tumor antigen.
@en
P2093
Bernard Lethé
Christophe Lurquin
Etienne De Plaen
Ivan Théate
Nicolas van Baren
Pierre G Coulie
Thierry Boon
Véronique Corbière
P2860
P304
P356
10.1084/JEM.20041378
P407
P577
2005-01-01T00:00:00Z